Home / Recalls / Akorn, Inc. / D-1172-2022

D-1172-2022 Class II Terminated

Recalled by Akorn, Inc. — Lake Forest, IL

FDA drug recall D-1172-2022 was initiated by Akorn, Inc. on Jun 13, 2022 and is designated Class II. Reason for recall: Defective container: defect prevents product from dispensing as intended. The recall status is terminated (terminated Jul 14, 2024). Affected quantity: 44,400 bottles.

Recall Details

Product Type: Drugs
Report Date: Jul 6, 2022
Initiation Date: Jun 13, 2022
Termination Date: Jul 14, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 44,400 bottles

Product Description

Fluticasone Propionate Nasal Spray, USP, 50 mcg, 16 g net fill weight per amber glass bottle, Rx only, Manufactured by: HI-TECH PHARMACAL CO., INC., Amityville, NY 11701. NDC 50383-700-16

Reason for Recall

Defective container: defect prevents product from dispensing as intended.

Distribution Pattern

Nationwide USA

Code Information

Lot #: 379073, 379079, Exp 9/30/2023

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-1172-2022
openFDA file date: Oct 23, 2026
Loaded by RegDataLab: Oct 25, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Akorn, Inc.

D-0794-2023 Class II — Clobetasol Propionate Cream, USP, 0.05%, packaged in a) 15g tubes, b) 30g tubes… (Apr 26, 2023)
D-0818-2023 Class II — Levofloxacin Injection 500mg/20 mL (25 mg/mL), For Intravenous Infusion… (Apr 26, 2023)
D-0799-2023 Class II — Dicyclomine Hydrochloride Injection USP, 20 mg/2 mL (10 mg/mL) ampules, 2 mL… (Apr 26, 2023)
D-0829-2023 Class II — Moxifloxacin HCl Ophthalmic Solution, USP, 0.5%, 3 mL bottles, Rx Only… (Apr 26, 2023)
D-0779-2023 Class II — Atropine Sulfate Ophthalmic Solution, USP 1%, For Topical Application To The… (Apr 26, 2023)
D-0825-2023 Class II — Lorazepam Injection, USP 2 mg/mL vial, 1 mL vials, Rx Only, Sterile… (Apr 26, 2023)
D-0801-2023 Class II — DOCU LIQUID (docusate sodium, 50 mg/5 mL), packaged in 473mL bottles and b)10mL… (Apr 26, 2023)
D-0823-2023 Class II — Lidocaine HCl Jelly USP, 2%, 5mL tubes, Rx Only, Manufactured by: Akorn, Inc… (Apr 26, 2023)
D-0816-2023 Class II — Levetiracetam Oral Solution 100 mg/mL (100 mg/mL), 473 mL, Rx Only, Distributed… (Apr 26, 2023)
D-0820-2023 Class II — Levofloxacin Ophthalmic Solution, 0.5%, 5 mL bottles, Rx Only, Manufactured by… (Apr 26, 2023)